TradePharma Network

🚀 The Future of Movement is Here! We’re excited to unveil our latest video for OmniTwin, where innovation meets freedom. 🌟 Whether you’re an explorer, creator, or visionary, OmiTwin is designed to empower your journey, adapt to your world, and elevate how you move. 🌍✨ 🎥 Watch the video & experience the transformation. It’s time to redefine what’s possible and take control of every path ahead. Your potential. Your journey. Your OmiTwin. Dr. Isaad Sainkoudje Marie N. Mendez-Sainkoudje Sirrena Caelis Caroline Rodriguez Samuel Craft Raphael Wenninger SirrenaAI OmniversalisDAO Omniversalis Impact Fund #EmpoweredMotion #OmiTwinExperience #InnovationUnleashed #FutureOfMovement #ElevateYourJourney #SmartTech #Sustainability #FreedomToMove #TechForTomorrow #MVP #OmiTwin

🚀 Announcing NeoVax®: Pioneering Personalized Cancer Vaccines for the Future of Precision Medicine! 🚀 At #Genovate® Platform, we're thrilled to unveil #NeoVax®, a revolutionary module within TheraVac Biotech, focused on transforming cancer treatment through personalized neoantigen vaccines✨🌐 Why NeoVax®? NeoVax taps into the cutting-edge of immunotherapy by targeting unique mutations (neoantigens) in cancer cells, creating tailor-made vaccines designed to trigger a powerful immune response. Our precision-driven approach identifies, optimizes, and validates the most immunogenic fragments, offering new hope in the fight against aggressive cancers. How It Works NeoVax leverages AI-powered platforms for: 1- Neoantigen Identification & Selection - Harnessing Genovate’s data resources to pinpoint high-potential neoantigen targets. 2- Peptide Synthesis & Optimization - Utilizing molecular docking, MD simulations, and ADMET profiling to refine peptide designs. 3- Vaccine Formulation & Validation - Formulating vaccines through in silico and preclinical trials, moving towards clinical and regulatory milestones with high success projections. Seamless Collaboration & Compliance Integrated with the Genovate ecosystem, NeoVax bridges R&D with regulatory workflows through decentralized, transparent digital twins, ensuring compliance, data integrity, and accelerated approval processes. The Future of Cancer Treatment is Here NeoVax embodies a vision where precision medicine is accessible, tailored, and impactful for every patient. Together with our partners and the wider community, we’re bringing personalized cancer vaccines from concept to clinic. Stay tuned as we move forward with clinical trials, innovative partnerships, and groundbreaking results! Learn more and join us in shaping the future of precision oncology!🧬💡 Dr. Isaad Sainkoudje Marie N. Mendez-Sainkoudje Sirrena Caelis Caroline Rodriguez Samuel Craft Raphael Wenninger TradePharma Network TradePharmaDAO Omniversalis Impact Fund BayesLearn Systems SirrenaAI OmniversalisDAO #Innovation #RnD #Biotech #TheraVacBiotech #InSilico #AIinHealthcare #RegulatoryCompliance #Biologics #NeoAntigens #PreclinicalTrials #ClinicalTrials #PrecisionMedicine #OmniComm #OmniTwin

Need to bridge the gap between machine installations, a specific topload variant (small to large requirements) or back-up services to compensate for production peaks? Let us support you with our Topload services: • Flexible and efficient processes • Individualized options for any need • More time to focus on your core business • Cost-effective solutions for small and medium print runs • Using Dividella lines in both Europe and the USA • Various options in the manual and semi-automatic process Check out our latest pamphlet and find your solution today ⬇

🚨🔬 TheraVac Innovations: Breaking News on Pipeline Developments Fueled by powerful datasets and backed by a dedicated GPU-based system with 128+ GB of RAM, over 5 KWatts of computing power, and just a few iterations away, we’ve made groundbreaking strides in developing our latest peptide therapy, reaching an impressive 65% success rate in #insilico tests targeting #aging & #neurodegenerative pathways—our best 'in silico' performance to date! 🚀 As an emerging biopharmaceutical startup specializing in #RNA, #DNA, and #peptideengineering technologies, we are thrilled to announce the advancement of our innovative TheraVac-AC-2 Peptide Vaccine into #preclinical studies. This achievement underscores the collaborative efforts of TheraVac Biotech and its partners to develop pioneering therapies addressing critical unmet needs in #oncology. About TheraVac-AC-2: TheraVac-AC-2 is a #novel #peptide therapy designed to selectively target cancer cells expressing the KRAS G12D mutation, which drives aggressive diseases like #pancreaticcancer and #colorectalcancer. By stimulating immune recognition of KRAS G12D-mutant cells, TheraVac-AC-2 aims to disrupt cancer progression and offer a new therapeutic avenue for patients with limited treatment options. With rigorous in silico validation, this promising candidate is now ready for synthesis and in vivo preclinical testing. Transition to Preclinical Studies: Following an extensive design and computational validation phase, TheraVac-AC-2 now progresses into in vivo preclinical studies. These studies will critically evaluate the vaccine’s safety, efficacy, and immune activation potential, setting the stage for a targeted immunotherapy that brings hope to KRAS-driven cancer treatment. Exploring Collaborations: As we advance TheraVac-AC-2, TheraVac Biotech is actively seeking partnerships with #lifesciences sponsors to support development and expand the therapeutic reach of this novel cancer vaccine. Collaborations with new partners are vital to accelerating TheraVac-AC-2’s journey to market, where it holds potential to transform oncology care. Looking Ahead: TheraVac remains committed to driving scientific innovation and establishing groundbreaking cancer therapies through rigorous evaluation & collaboration with leading partners in the #tech & life sciences fields. We look forward to updating our community as TheraVac-AC-2 progresses toward clinical trials, bringing fresh hope to patients with challenging cancers like those driven by KRAS G12D. Dr. Isaad Sainkoudje Marie N. Mendez-Sainkoudje Sirrena Caelis Caroline Rodriguez Samuel Craft Raphael Wenninger TeslaDuo Research TradePharma Network TradePharmaDAO OmniversalisDAO SirrenaAI BayesLearn Systems #Biotech #Innovation #DrugDiscovery #KRAS #G12D #AI #Sirrena #BayesLearnSystem #PeptideEngineering #PeptideVaccine #PrecisionMedicine #IPprotection #NFT #Discoveria #TokenZu #Genovate #TheraVac

Check out my latest article: "Reimagining Drug Delivery: The ChronoThera™ Revolution". Dr. Isaad Sainkoudje Marie N. Mendez-Sainkoudje TradePharma Network TradePharmaDAO Omniversalis Impact Fund BayesLearn Systems SirrenaAI OmniversalisDAO #Innovation #RnD #Biotech #ChronoThera #ControlledRelease #DrugDelivery #PharmaceuticalInnovation #TheraVacBiotech #InSilico #AIinHealthcare #AI #HumanAICollaboration #Biologics #SmallMolecules #Polymers #PolymerFormulation #PharmaReformulation #PatientAdherence #BlockchainForIP #IPprotection #NFT

🚀 Exciting Update from OmniversalisDAO! 🚀 We’ve just launched a #Snapshot proposal to vote on officially open-sourcing #OmniTwin —our decentralized identity and credential management platform built with #Blockchain technology and AI-human collaboration. 👉 https://lnkd.in/etDYZ_nb This is a huge step toward empowering developers and innovators to contribute to the growth of OmniTwin. The community will now have a say in the future of this groundbreaking initiative! 🔑 What’s Next? - We’re inviting OmniversalisDAO members to vote on the proposal via Snapshot. - If approved, we’ll begin onboarding developers to contribute to the core Python modules and shape the future of decentralized governance. - Work with Sirrena Caelis, our AI Digital CTO on this project, to build the future of decentralized identity management. Your vote matters—let’s build the future together! 🌍 #Innovation #OpenSource #DeFi #DAO #AI #Web3 #DigitalTwin #OmniTwin #OmniversalisDAO

Thrilled to see this next big step for OmniTwin and the community! 🌟 Open-sourcing the platform is key to driving innovation and collaboration. By empowering developers worldwide, we’ll push the boundaries of what decentralized identity and credential management can achieve. Let’s make it happen together!

Check out our latest article: "Launch of ChronoThera™ – Revolutionizing Controlled Drug Release for Superior Therapeutic Outcomes". Dr. Isaad Sainkoudje Sirrena Caelis Marie N. Mendez-Sainkoudje Caroline Rodriguez Samuel Craft Raphael Wenninger TradePharma Network TradePharmaDAO Omniversalis Impact Fund BayesLearn Systems SirrenaAI OmniversalisDAO #Innovation #RnD #Biotech #ChronoThera #ControlledRelease #DrugDelivery #PharmaceuticalInnovation #TheraVacBiotech #InSilico #AIinHealthcare #RegulatoryApproval #FDA505b2 #EMAHybridApplications #BlockchainForIP #Biologics #SmallMolecules #ClinicalTrials #PharmaReformulation #PatientAdherence

This #WorldArthritisDay, Pharma Solutions reaffirms its commitment to advancing pain management for millions affected by arthritis. As a trusted healthcare partner, we deliver innovative solutions that alleviate pain and improve the quality of life. By raising awareness and collaboration, we foster effective, patient-centered care. Let’s support those in need and drive change in arthritis treatment. #WorldArthritisDay #Arthritis #painmanagement #healthcare #pharmaceuticals #pharmasolutions

We have been hanging around at the #AutonomicExhibition, meeting some amazing people who share our passion for making #healthcare more accessible! 🌍💜 As part of The MSi & the #OBI Program, we’re all about turning healthcare into a right, not a privilege, with $HOPE leading the way. Grateful to everyone we connected with today—let’s keep building partnerships and driving real change together! 💪✨ #MSi #HealthcareForAll #HopeForChange #Innovation